Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Jul 2, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Intra-Cellular Therapies, Inc.
262
$68.49
$17,944.38
+0.22%
116.86K
Jun 28
Intra-Cellular Therapies, Inc.
17.11K
$46.22
-$337,193.34
+17.19%
116.6K
Jun 23 - Jun 24
Intra-Cellular Therapies, Inc.
0
—
—
—
0
Jun 14
Cibus, Inc.
98.04K
$10.20
$1,000,008.00
+3.16%
3.2M
Jun 11
Intra-Cellular Therapies, Inc.
260
$69.20
$17,992.00
+0.26%
99.5K
Mar 31
Intra-Cellular Therapies, Inc.
20K
$18.56
$371,200.00
+25.24%
99.23K
Mar 20
Royalty Pharma Plc
300K
—
—
+1,492.61%
320.1K
Feb 20
Royalty Pharma Plc
-470.00K
$28.13
-$13,222,861.61
-95.90%
20.1K
Jan 2 - Jan 4
Scheduled
Cibus, Inc.
1.51M
—
—
+50.79%
4.47M
Dec 29
Intra-Cellular Therapies, Inc.
251
$71.62
$17,976.62
+0.32%
79.23K
Dec 31
Cibus, Inc.
477.63K
$10.58
$5,470,992.06
+21.23%
2.73M
Sep 27 - Dec 12
Royalty Pharma Plc
475.59K
—
—
+3,277.90%
490.1K
Nov 13
Intra-Cellular Therapies, Inc.
345
$52.09
$17,971.05
+0.44%
78.98K
Sep 30
Royalty Pharma Plc
0
—
—
—
0
Aug 8
Intra-Cellular Therapies, Inc.
279
$63.32
$17,666.28
+0.36%
78.64K
Jun 30
Intra-Cellular Therapies, Inc.
0
—
—
—
0
Jun 23
Royalty Pharma Plc
7.75K
—
—
+114.57%
14.51K
Jun 23
Cibus, Inc.
0
—
—
—
0
Cibus, Inc.
4.04M
$31.50
—
+78.62%
9.18M
May 31 - Jun 1
Cibus, Inc.
0
—
—
—
0
Royalty Pharma Plc
-1.75M
$32.82
-$57,435,000.00
-99.62%
6.76K
May 22
Royalty Pharma Plc
300K
—
—
+20.59%
1.76M
May 9
Intra-Cellular Therapies, Inc.
313
$54.15
$16,948.95
+0.40%
78.36K
Mar 31
Royalty Pharma Plc
-139.95K
$36.31
-$5,081,110.88
-8.76%
1.46M
Mar 29 - Mar 30
Royalty Pharma Plc
1.5M
—
—
+1,551.00%
1.6M
Feb 17
Intra-Cellular Therapies, Inc.
321
$52.92
$16,987.32
+0.41%
78.05K
Dec 30
Royalty Pharma Plc
-60.00K
$42.01
-$2,520,623.14
-38.29%
96.71K
Dec 12 - Dec 9
Royalty Pharma Plc
-120.00K
$42.33
-$5,079,924.00
-43.37%
156.71K
Nov 17
Intra-Cellular Therapies, Inc.
365
$46.53
$16,983.45
+0.47%
77.73K
Sep 30
Royalty Pharma Plc
-100.00K
$42.30
-$4,230,387.49
-26.55%
276.71K
Sep 14 - Sep 15
Royalty Pharma Plc
-45.00K
$43.73
-$1,967,823.00
-10.67%
376.71K
Aug 9
Intra-Cellular Therapies, Inc.
289
$57.08
$16,496.12
+0.37%
77.36K
Jun 30
Royalty Pharma Plc
-30.00K
$42.17
-$1,265,238.00
-6.64%
421.71K
Jun 29
Intra-Cellular Therapies, Inc.
0
—
—
—
0
Jun 9
Royalty Pharma Plc
-150.00K
$39.42
-$5,913,306.17
-24.93%
451.71K
May 19 - May 20
Intra-Cellular Therapies, Inc.
257
$61.19
$15,725.83
+0.33%
77.07K
Mar 31
Royalty Pharma Plc
-60.00K
$38.59
-$2,315,322.00
-9.07%
601.71K
Mar 29
Royalty Pharma Plc
-1.94M
$39.44
—
-72.17%
746.9K
Mar 17 - Mar 21
Intra-Cellular Therapies, Inc.
-226.67K
$60.10
-$13,623,978.69
-100.00%
0
Mar 16 - Mar 18
Intra-Cellular Therapies, Inc.
300
$52.34
$15,702.00
+0.39%
76.81K
Dec 31

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.